Table 1 Characteristics of sample separated by severity category
From: The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in Kenya
CD4 < 200 N = 364 N (%) | CD4 ≥ 200 N = 169 N (%) | VLa >55,000 N = 281 N (%) | VLa ≤55,000 N = 214 N (%) | Stage 1 N = 114 N (%) | Stage 2 N = 126 N (%) | Stage 3 N = 204 N (%) | Stage 4 N = 22 N (%) | |
|---|---|---|---|---|---|---|---|---|
Male Gender | 136 (37) | 51 (30) | 114 (41) | 62 (29) | 30 (26) | 48 (38) | 72 (35) | 7 (32) |
Age | ||||||||
20–29 | 62 (17) | 37 (22) | 46 (16) | 43 (20) | 30 (26) | 19 (15) | 39 (19) | 4(18) |
30–39 | 184 (51) | 88 (52) | 148 (53) | 104 (49) | 63 (55) | 59 (47) | 95 (47) | 10 (45) |
40–49 | 89 (24) | 32 (19) | 68 (24) | 48 (22) | 16 (14) | 24 (19) | 51 (25) | 8 (36) |
50+ | 30 (8) | 12 (7) | 19 (7) | 19 (9) | 5 (4) | 3 (2) | 19 (9) | 0 (0) |
Income (Schillings) | ||||||||
≤ 2000 | 93 (29) | 43 (29) | 58 (23) | 65 (35) | 26 (27) | 29 (25) | 57 (32) | 6 (30) |
2001–10,000 | 140 (43) | 71 (48) | 114 (45) | 80 (43) | 41 (43) | 59 (51) | 84 (48) | 4 (20) |
10,001–40,000 | 75 (23) | 30 (20) | 64 (25) | 36 (19) | 25 (26) | 24 (20) | 27 (15) | 10 (50) |
> 40,000 | 14 (4) | 5 (3) | 15 (6) | 4 (2) | 3 (3) | 3 (2) | 8 (5) | 0 (0) |
Urban Res. | 295 (81) | 139 (82) | 238 (85) | 170 (79) | 107 (94) | 116 (92) | 137 (67) | 18 (82) |